Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Snow
M M Mitchell

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology|July 7, 2015
Self-reported student confidence in troubleshooting ability increases after completion of an inquiry-based PCR practicalAnthony L Cook, Elizabeth T Snow, Henrica Binns, et al.
Mutation Research|January 16, 1994
Transgenic gpt+ V79 cell lines differ in their mutagenic response to clastogensC B Klein, L Su, T G Rossman, et al.
Environmental and Molecular Mutagenesis|January 1, 1994
Propylene oxide mutagenesis at template cytosine residuesE T Snow, J Singh, K L Koenig, et al.
Journal of Cutaneous Pathology|October 12, 2022
Cutaneous metastases of non-cutaneous neuroendocrine neoplasms: A histopathologic review of 15 casesMisty M Hobbs, Justin T Snow, Tracy R Shachner, et al.
International Journal of Pharmaceutical Compounding|January 23, 2019
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the LineStephen T Snow, Robert W Stannard, Jennifer Bellis, et al.
Advances in Experimental Medicine and Biology|January 1, 1977
Inhibitory effect of mercaptoamino acids on lysino-alanine formation during alkali treatment of proteinsJ W Finley, J T Snow, P H Johnston, et al.
Critical Reviews in Toxicology|January 1, 1989
Toxicity and carcinogenicity of nickel compoundsT P Coogan, D M Latta, E T Snow, et al.
Toxicology and Applied Pharmacology|July 6, 2005
Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?Elizabeth T Snow, Peter Sykora, Troy R Durham, et al.
Methods in Molecular Medicine|March 8, 2011
Quantitative immunoblotting with fusion proteinsM M Mitchell, L D Loomis-Price
Basic Life Sciences|January 1, 1986
Apurinic sites as common intermediates in mutagenesisL A Loeb, B D Preston, E T Snow, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology|July 7, 2015
Self-reported student confidence in troubleshooting ability increases after completion of an inquiry-based PCR practicalAnthony L Cook, Elizabeth T Snow, Henrica Binns, et al.
Mutation Research|January 16, 1994
Transgenic gpt+ V79 cell lines differ in their mutagenic response to clastogensC B Klein, L Su, T G Rossman, et al.
Environmental and Molecular Mutagenesis|January 1, 1994
Propylene oxide mutagenesis at template cytosine residuesE T Snow, J Singh, K L Koenig, et al.
Journal of Cutaneous Pathology|October 12, 2022
Cutaneous metastases of non-cutaneous neuroendocrine neoplasms: A histopathologic review of 15 casesMisty M Hobbs, Justin T Snow, Tracy R Shachner, et al.
International Journal of Pharmaceutical Compounding|January 23, 2019
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the LineStephen T Snow, Robert W Stannard, Jennifer Bellis, et al.
Advances in Experimental Medicine and Biology|January 1, 1977
Inhibitory effect of mercaptoamino acids on lysino-alanine formation during alkali treatment of proteinsJ W Finley, J T Snow, P H Johnston, et al.
Critical Reviews in Toxicology|January 1, 1989
Toxicity and carcinogenicity of nickel compoundsT P Coogan, D M Latta, E T Snow, et al.
Toxicology and Applied Pharmacology|July 6, 2005
Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?Elizabeth T Snow, Peter Sykora, Troy R Durham, et al.
Methods in Molecular Medicine|March 8, 2011
Quantitative immunoblotting with fusion proteinsM M Mitchell, L D Loomis-Price
Basic Life Sciences|January 1, 1986
Apurinic sites as common intermediates in mutagenesisL A Loeb, B D Preston, E T Snow, et al.
Pageof 16